
X
Daiichi gets speedy FDA review for rare cancer drug
https://pharmaphorum.com/news/daiichi-speedy-fda-review-rare-cancer-drug/
Trading in shares of Daiichi Sankyo was suspended yesterday.
Label gives guidance in use when restoring normal heart rhythm
Japanese R&D investment could follow EMA out of UK – experts.